Literature DB >> 23879365

Developmental trajectory of intestinal MDR1/ABCB1 mRNA expression in children.

Tomoyuki Mizuno1, Tsuyoshi Fukuda, Satohiro Masuda, Shinji Uemoto, Kazuo Matsubara, Ken-Ichi Inui, Alexander A Vinks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23879365      PMCID： PMC4004414          DOI： 10.1111/bcp.12211

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.

Authors:  Satohiro Masuda; Maki Goto; Sachio Fukatsu; Miwa Uesugi; Yasuhiro Ogura; Fumitaka Oike; Tetsuya Kiuchi; Yasutsugu Takada; Koichi Tanaka; Ken-Ichi Inui
Journal:  Clin Pharmacol Ther       Date:  2006-01       Impact factor: 6.875

Review 2.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  Ontogeny of oral drug absorption processes in children.

Authors:  Miriam G Mooij; Barbara A E de Koning; Mark L Huijsman; Saskia N de Wildt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-06-11       Impact factor: 4.481

4.  Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis.

Authors:  T N Johnson; M S Tanner; C J Taylor; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

5.  P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis.

Authors:  Yigit S Guner; Ashanti L Franklin; Nikunj K Chokshi; Shannon L Castle; Elizabeth Pontarelli; Jin Wang; Larry Wang; Nemani V Prasadarao; Jeffrey S Upperman; Anatoly V Grishin; Henri R Ford
Journal:  Lab Invest       Date:  2011-07-25       Impact factor: 5.662

6.  Multidrug resistance gene (P-glycoprotein) expression in the human fetus.

Authors:  C K van Kalken; G Giaccone; P van der Valk; C M Kuiper; M M Hadisaputro; S A Bosma; R J Scheper; C J Meijer; H M Pinedo
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

Review 7.  Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Authors:  Gregory L Kearns; Susan M Abdel-Rahman; Sarah W Alander; Douglas L Blowey; J Steven Leeder; Ralph E Kauffman
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

Review 8.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468
  8 in total
  11 in total

Review 1.  Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.

Authors:  K L R Brouwer; L M Aleksunes; B Brandys; G P Giacoia; G Knipp; V Lukacova; B Meibohm; S K Nigam; M Rieder; S N de Wildt
Journal:  Clin Pharmacol Ther       Date:  2015-09       Impact factor: 6.875

2.  A proof of concept using the Ussing chamber methodology to study pediatric intestinal drug transport and age-dependent differences in absorption.

Authors:  Eva J Streekstra; Márton Kiss; Jeroen van den Heuvel; Johan Nicolaï; Petra van den Broek; Sanne M B I Botden; Martijn W J Stommel; Lara van Rijssel; Anna-Lena Ungell; Evita van de Steeg; Frans G M Russel; Saskia N de Wildt
Journal:  Clin Transl Sci       Date:  2022-08-12       Impact factor: 4.438

3.  Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.

Authors:  Noël Knops; Jean Herman; Maria van Dyck; Yasaman Ramazani; Edward Debbaut; Rita van Damme-Lombaerts; Elena Levtchenko; Lambertus P van den Heuvel; Steffen Fieuws; Dirk Kuypers
Journal:  Br J Clin Pharmacol       Date:  2016-12-13       Impact factor: 4.335

4.  Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.

Authors:  Miriam G Mooij; Ute I Schwarz; Barbara A E de Koning; J Steven Leeder; Roger Gaedigk; Janneke N Samsom; Edwin Spaans; Johannes B van Goudoever; Dick Tibboel; Richard B Kim; Saskia N de Wildt
Journal:  Drug Metab Dispos       Date:  2014-05-14       Impact factor: 3.922

Review 5.  Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters.

Authors:  Kit Wun Kathy Cheung; Bianca D van Groen; Gilbert J Burckart; Lei Zhang; Saskia N de Wildt; Shiew-Mei Huang
Journal:  J Clin Pharmacol       Date:  2019-09       Impact factor: 3.126

Review 6.  Recent advances in the ontogeny of drug disposition.

Authors:  Brian D Chapron; Alenka Chapron; J Steven Leeder
Journal:  Br J Clin Pharmacol       Date:  2021-04-15       Impact factor: 3.716

Review 7.  Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.

Authors:  Jean-Marie Nicolas; François Bouzom; Chanteux Hugues; Anna-Lena Ungell
Journal:  Biopharm Drug Dispos       Date:  2017-02-06       Impact factor: 1.627

8.  Lobular Distribution and Variability in Hepatic ATP Binding Cassette Protein B1 (ABCB1, P-gp): Ontogenetic Differences and Potential for Toxicity.

Authors:  Ngu Njei Abanda; Zoe Riches; Abby C Collier
Journal:  Pharmaceutics       Date:  2017-02-17       Impact factor: 6.321

Review 9.  Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.

Authors:  Miriam G Mooij; Anne T Nies; Catherijne A J Knibbe; Elke Schaeffeler; Dick Tibboel; Matthias Schwab; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

10.  Model-Informed Drug Development for Everolimus Dosing Selection in Pediatric Infant Patients.

Authors:  Francois Pierre Combes; Heidi J Einolf; Neva Coello; Tycho Heimbach; Handan He; Kai Grosch
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.